Daniel Checketts

2.8k total citations · 2 hit papers
29 papers, 1.7k citations indexed

About

Daniel Checketts is a scholar working on Pharmacology, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Daniel Checketts has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 17 papers in Psychiatry and Mental health and 7 papers in Genetics. Recurrent topics in Daniel Checketts's work include Cannabis and Cannabinoid Research (21 papers), Epilepsy research and treatment (15 papers) and Hemoglobinopathies and Related Disorders (6 papers). Daniel Checketts is often cited by papers focused on Cannabis and Cannabinoid Research (21 papers), Epilepsy research and treatment (15 papers) and Hemoglobinopathies and Related Disorders (6 papers). Daniel Checketts collaborates with scholars based in United Kingdom, United States and Spain. Daniel Checketts's co-authors include Orrin Devinsky, Anup D. Patel, Claire Roberts, Vicente Villanueva, J. Helen Cross, Elaine Wirrell, Michael Privitera, Kevan VanLandingham, Sameer M. Zuberi and Sam M. Greenwood and has published in prestigious journals such as New England Journal of Medicine, Neurology and British Journal of Cancer.

In The Last Decade

Daniel Checketts

28 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

2018 661 citations Orrin Devinsky, Anup D. Patel et al. New England Journal of Medicine profile →
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome

2020 192 citations Ian Miller, Ingrid E. Scheffer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Checketts United Kingdom	17	1.2k	922	560	369	172	29	1.7k
Claire Roberts United Kingdom	8	731 0.6×	596 0.6×	369 0.7×	224 0.6×	136 0.8×	17	1.2k
Gilmour Morrison United Kingdom	10	1.0k 0.9×	436 0.5×	297 0.5×	184 0.5×	96 0.6×	16	1.2k
Robert Flamini United States	12	496 0.4×	584 0.6×	323 0.6×	310 0.8×	83 0.5×	21	957
Patricia L. Bruno United States	10	491 0.4×	469 0.5×	275 0.5×	192 0.5×	124 0.7×	14	884
Boudewijn Gunning Netherlands	18	392 0.3×	838 0.9×	476 0.8×	312 0.8×	292 1.7×	23	1.3k
Alexandra L. Geffrey United States	7	438 0.4×	381 0.4×	227 0.4×	144 0.4×	109 0.6×	12	718
E. Martina Bebin United States	16	353 0.3×	396 0.4×	281 0.5×	130 0.4×	357 2.1×	22	1.1k
Barbara Błaszczyk Poland	15	157 0.1×	596 0.6×	411 0.7×	485 1.3×	65 0.4×	31	1.2k
Steve Chung United States	23	192 0.2×	1.5k 1.6×	665 1.2×	1.2k 3.2×	145 0.8×	58	1.9k
Terri Sebree United States	16	505 0.4×	627 0.7×	132 0.2×	43 0.1×	126 0.7×	43	1.4k

Countries citing papers authored by Daniel Checketts

Since Specialization

Citations

This map shows the geographic impact of Daniel Checketts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Checketts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Checketts more than expected).

Fields of papers citing papers by Daniel Checketts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Checketts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Checketts. The network helps show where Daniel Checketts may publish in the future.

Co-authorship network of co-authors of Daniel Checketts

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Checketts. A scholar is included among the top collaborators of Daniel Checketts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Checketts. Daniel Checketts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Béthoux, François, Rachel Farrell, Daniel Checketts, et al.. (2024). A randomized, double-blind, placebo-controlled trial to evaluate the effect of nabiximols oromucosal spray on clinical measures of spasticity in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 89. 105740–105740. 1 indexed citations

Weinstock, Arie, E. Martina Bebin, Daniel Checketts, et al.. (2024). Long‐term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3‐year results from the cannabidiol expanded access program. Epilepsia Open. 9(5). 1816–1825. 3 indexed citations

Lublin, Fred, et al.. (2023). Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials. Multiple Sclerosis and Related Disorders. 75. 104745–104745. 10 indexed citations

Wu, Joyce Y., Hannah R. Cock, Orrin Devinsky, et al.. (2022). Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6. Epilepsia. 63(5). 1189–1199. 16 indexed citations

Szaflarski, Jerzy P., Orrin Devinsky, Yong D. Park, et al.. (2022). Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant epilepsies: Four‐year results from the expanded access program. Epilepsia. 64(3). 619–629. 21 indexed citations

Twelves, Chris, Michael Sabel, Daniel Checketts, et al.. (2021). A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma. British Journal of Cancer. 124(8). 1379–1387. 78 indexed citations

Wu, Joyce Y., Hannah R. Cock, Orrin Devinsky, et al.. (2020). Time to Onset of Cannabidiol (CBD) Treatment Effect and Resolution of Adverse Events (AEs) in the Tuberous Sclerosis Complex (TSC) Phase 3 Randomized Controlled Trial (GWPCARE6) (674). Neurology. 94(15_supplement). 6 indexed citations

Taylor, Lesley, Julie C. Crockett, Bola Tayo, Daniel Checketts, & Kenneth W. Sommerville. (2020). Abrupt withdrawal of cannabidiol (CBD): A randomized trial. Epilepsy & Behavior. 104(Pt A). 106938–106938. 37 indexed citations

Patel, Anup D., Richard Chin, Wendy G. Mitchell, et al.. (2020). Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Patients with Lennox Gastaut Syndrome (LGS): 3-Year Results of an Open-Label Extension (OLE) Trial (GWPCARE5) (668). Neurology. 94(15_supplement). 1 indexed citations

10.

Gunning, Boudewijn, Maria Mazurkiewicz‐Bełdzińska, Richard Chin, et al.. (2020). Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials. Acta Neurologica Scandinavica. 143(2). 154–163. 32 indexed citations

11.

Devinsky, Orrin, Elizabeth A. Thiele, Stephen Wright, et al.. (2020). Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials. Acta Neurologica Scandinavica. 142(6). 531–540. 40 indexed citations

12.

Miller, Ian, Ingrid E. Scheffer, Boudewijn Gunning, et al.. (2019). Cannabidiol (CBD; 10 And 20 MG/KG/Day) Significantly Reduces Convulsive Seizure Frequency In Children And Adolescents With Dravet Syndrome: Results Of A Dose-Ranging, Multi-Center, Randomised, Double-Blind, Placebo-Controlled Trial (GWPCARE2). Epilepsia. 60. 1 indexed citations

13.

Thiele, Elizabeth A., Eric D. Marsh, Maria Mazurkiewicz‐Bełdzińska, et al.. (2019). Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study. Epilepsia. 60(3). 419–428. 103 indexed citations

14.

Laux, Linda, E. Martina Bebin, Daniel Checketts, et al.. (2019). Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy Research. 154. 13–20. 143 indexed citations

15.

Mazurkiewicz‐Bełdzińska, Maria, Michael Privitera, Eric D. Marsh, et al.. (2019). Time to Onset of Efficacy of Cannabidiol (CBD) During Titration in Patients with Lennox-Gastaut Syndrome and Dravet Syndrome Enrolled in Three Randomized Controlled Trials (S48.009). Neurology. 92(15_supplement).

16.

Mazurkiewicz‐Bełdzińska, Maria, Michael Privitera, Eric D. Marsh, et al.. (2019). Time to Onset of Efficacy of Cannabidiol (CBD) During Titration in Patients with Lennox-Gastaut Syndrome or Dravet Syndrome Enrolled in Three Randomised Controlled Trials. Neuropediatrics. 1 indexed citations

17.

Szaflarski, Jerzy P., E. Martina Bebin, Anne M. Comi, et al.. (2018). Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results. Epilepsia. 59(8). 1540–1548. 158 indexed citations

18.

Halford, Jonathan J., Eric D. Marsh, Maria Mazurkiewicz‐Bełdzińska, et al.. (2018). Long-term Safety and Efficacy of Cannabidiol (CBD) in Patients with Lennox-Gastaut Syndrome (LGS): Results from Open-label Extension Trial (GWPCARE5) (P1.264). Neurology. 90(15_supplement). 2 indexed citations

19.

Devinsky, Orrin, Anup D. Patel, J. Helen Cross, et al.. (2018). Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome. New England Journal of Medicine. 378(20). 1888–1897. 661 indexed citations breakdown →

20.

Smith, Guy T., et al.. (2012). Evaluation and Calibration of a Binocular Infrared Pupillometer for Measuring Relative Afferent Pupillary Defect. Journal of Neuro-Ophthalmology. 32(2). 111–115. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact